Literature DB >> 27477967

The risks behind Dengvaxia recommendation.

Maíra Aguiar1, Nico Stollenwerk2, Scott B Halstead3.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27477967     DOI： 10.1016/S1473-3099(16)30168-2

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  25 in total

1.  NS3 helicase from dengue virus specifically recognizes viral RNA sequence to ensure optimal replication.

Authors:  Crystall M D Swarbrick; Chandrakala Basavannacharya; Kitti W K Chan; Shu-Ann Chan; Daljit Singh; Na Wei; Wint Wint Phoo; Dahai Luo; Julien Lescar; Subhash G Vasudevan
Journal:  Nucleic Acids Res       Date:  2017-12-15       Impact factor: 16.971

2.  A novel immunization approach for dengue infection based on conserved T cell epitopes formulated in calcium phosphate nanoparticles.

Authors:  Xiaofang Huang; Aykan Karabudak; Joseph D Comber; Mohan Philip; Tulin Morcol; Ramila Philip
Journal:  Hum Vaccin Immunother       Date:  2017-09-21       Impact factor: 3.452

3.  Modeling the initial phase of COVID-19 epidemic: The role of age and disease severity in the Basque Country, Spain.

Authors:  Akhil Kumar Srivasrav; Nico Stollenwerk; Joseba Bidaurrazaga Van-Dierdonck; Javier Mar; Oliver Ibarrondo; Maíra Aguiar
Journal:  PLoS One       Date:  2022-07-13       Impact factor: 3.752

4.  Universal Dengue Vaccine Elicits Neutralizing Antibodies against Strains from All Four Dengue Virus Serotypes.

Authors:  Naoko Uno; Ted M Ross
Journal:  J Virol       Date:  2021-01-28       Impact factor: 5.103

5.  The Dengue Vaccine Dilemma: Balancing the Individual and Population Risks and Benefits.

Authors:  Jacqueline Deen
Journal:  PLoS Med       Date:  2016-11-29       Impact factor: 11.069

6.  The Impact of the Newly Licensed Dengue Vaccine in Endemic Countries.

Authors:  Maíra Aguiar; Nico Stollenwerk; Scott B Halstead
Journal:  PLoS Negl Trop Dis       Date:  2016-12-21

7.  Cost-Effectiveness of Dengue Vaccination Programs in Brazil.

Authors:  Eunha Shim
Journal:  Am J Trop Med Hyg       Date:  2017-05       Impact factor: 2.345

8.  Cost-effectiveness of dengue vaccination in Yucatán, Mexico using a dynamic dengue transmission model.

Authors:  Eunha Shim
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

9.  Human macrophages differentiated in the presence of vitamin D3 restrict dengue virus infection and innate responses by downregulating mannose receptor expression.

Authors:  John F Arboleda Alzate; Izabela A Rodenhuis-Zybert; Juan C Hernández; Jolanda M Smit; Silvio Urcuqui-Inchima
Journal:  PLoS Negl Trop Dis       Date:  2017-10-11

Review 10.  Dengue virus and the host innate immune response.

Authors:  Naoko Uno; Ted M Ross
Journal:  Emerg Microbes Infect       Date:  2018-10-10       Impact factor: 7.163
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.